{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:24:15Z","timestamp":1793247855840,"version":"4.5.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shandong Provincial Medical and Health Science and Technology Project.","award":["202303041667"],"award-info":[{"award-number":["202303041667"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aplastic anemia (AA) is a life-threatening blood disorder characterized by bone marrow failure and pancytopenia. Treatments such as immunosuppressive therapy (IST) and allogeneic hematopoietic stem cell transplantation (allo-HSCT) have limitations, including poor long-term remission and donor shortages. Exosomes, nanosized extracellular vesicles, are promising drug delivery systems (DDS) due to their biocompatibility, targeted delivery, and capacity to penetrate biological barriers. Traditional Chinese medicine (TCM) regulates hematopoiesis and immunity but faces challenges with delivery. This review discusses exosomes loaded with TCM constituents (Exo-TCM) for AA, summarizing AA pathogenesis, exosome features, TCM potential, Exo-TCM preparation, and preclinical efficacy, and translational challenges, highlighting Exo-TCM as a novel therapeutic approach for AA.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13020-026-01330-2","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:56:38Z","timestamp":1769414198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exosomes-loaded with traditional Chinese medicine constituents: a novel therapeutic avenue for aplastic anemia"],"prefix":"10.1186","volume":"21","author":[{"given":"Guo-Kai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"2","key":"1330_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ejh.13991","volume":"111","author":"H Li","year":"2023","unstructured":"Li H, Zhou C, Shen Y, Xu M, Wu D, Ye B. Research progress on the hematopoietic microenvironment in aplastic anemia. Eur J Haematol. 2023;111(2):172\u201380.","journal-title":"Eur J Haematol"},{"issue":"11","key":"1330_CR2","first-page":"e73403","volume":"16","author":"M Rodriguez-Sevilla","year":"2024","unstructured":"Rodriguez-Sevilla M, Valverde-Munoz K, Garcia-Hernandez C, Sanabria-Castro A, Echeverri-McCandless A, Rojas-Chaves S. Aplastic anemia: demographic and clinical characteristics in Costa Rica. Cureus. 2024;16(11):e73403.","journal-title":"Cureus"},{"issue":"4","key":"1330_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4196\/kjpp.24.214","volume":"29","author":"MA Ucar","year":"2025","unstructured":"Ucar MA, Sener M, Dokuyucu R. Current view on the etiopathogenesis of aplastic anemia. Korean J Physiol Pharmacol. 2025;29(4):399\u2013408.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"12","key":"1330_CR4","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/cbin.11689","volume":"45","author":"MR Javan","year":"2021","unstructured":"Javan MR, Saki N, Moghimian-Boroujeni B. Aplastic anemia, cellular and molecular aspects. Cell Biol Int. 2021;45(12):2395\u2013402.","journal-title":"Cell Biol Int"},{"issue":"6","key":"1330_CR5","first-page":"e40210","volume":"15","author":"E Proskuriakova","year":"2023","unstructured":"Proskuriakova E, Jasaraj RB, San Hernandez AM, Sakhuja A, Khoury M, Khosla P. A case of severe aplastic anemia in a 35-year-old male with a good response to immunosuppressive therapy. Cureus. 2023;15(6):e40210.","journal-title":"Cureus"},{"key":"1330_CR6","doi-asserted-by":"publisher","first-page":"e01826","DOI":"10.1016\/j.idcr.2023.e01826","volume":"33","author":"S Pvs","year":"2023","unstructured":"Pvs S, Koka H, Suvvari TK, Mounish Reddy R, Godavari ST, Thomas V. An unusual case of acquired aplastic anemia following SARS-CoV-2 vaccination: a case report. IDCases. 2023;33:e01826.","journal-title":"IDCases"},{"key":"1330_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810160","author":"LQ Vu","year":"2024","unstructured":"Vu LQ, Espinoza JL, Nguyen HTG, Mizuno S, Takami A. MAIT cells in the bone marrow of patients with aplastic anemia. Int J Mol Sci. 2024.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1330_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10238-021-00701-3","volume":"21","author":"QZ Shi","year":"2021","unstructured":"Shi QZ, Yu HM, Chen HM, Liu M, Cheng X. Exosomes derived from mesenchymal stem cells regulate Treg\/Th17 balance in aplastic anemia by transferring miR-23a-3p. Clin Exp Med. 2021;21(3):429\u201337.","journal-title":"Clin Exp Med"},{"issue":"5","key":"1330_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10517-022-05453-y","volume":"172","author":"AI Dorofeeva","year":"2022","unstructured":"Dorofeeva AI, Shipunova IN, Drize NI, Luchkin AV, Abramova AV, Fidarova ZT, et al. Bone marrow multipotent mesenchymal stromal cells from patients with aplastic anemia retain their ability to support hematopoietic precursors despite pronounced changes in gene expression. Bull Exp Biol Med. 2022;172(5):637\u201341.","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"1330_CR10","first-page":"177","volume":"33","author":"F Nejatifar","year":"2023","unstructured":"Nejatifar F, Hesni E, Samadani AA. A novel case report of severe aplastic anemia with COVID infection. Ethiop J Health Sci. 2023;33(1):177\u201381.","journal-title":"Ethiop J Health Sci"},{"key":"1330_CR11","first-page":"103998","volume":"79","author":"AM Bhattarai","year":"2022","unstructured":"Bhattarai AM, Dhakal B, Rokaya P, Karki A, Gurung S, Baral S. Aplastic anemia induced by human parvovirus B19 infection in an immunocompetent adult male without prior hematological disorders: a case report. Ann Med Surg (Lond). 2022;79:103998.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"1330_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.seminhematol.2022.01.002","volume":"59","author":"BA Patel","year":"2022","unstructured":"Patel BA, Townsley DM, Scheinberg P. Immunosuppressive therapy in severe aplastic anemia. Semin Hematol. 2022;59(1):21\u20139.","journal-title":"Semin Hematol"},{"issue":"5","key":"1330_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MPH.0000000000001916","volume":"43","author":"J Lapinski","year":"2021","unstructured":"Lapinski J, Nolfi-Donegan D, Cooper JD, Squires RH. Atypical outcomes for hepatitis-associated acquired aplastic anemia: 2 case studies and review of the literature. J Pediatr Hematol Oncol. 2021;43(5):195\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"1330_CR14","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.21037\/apm-21-1049","volume":"10","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wu Y, Liu J, Han S, Chen L, Wang H, et al. A systematic review and meta-analysis of the safety and efficacy of anti-thymocyte globulin combined with eltrombopag in the treatment of severe aplastic anemia. Ann Palliat Med. 2021;10(5):5549\u201360.","journal-title":"Ann Palliat Med"},{"issue":"1","key":"1330_CR15","first-page":"e20955","volume":"14","author":"MR Tapdia","year":"2022","unstructured":"Tapdia MR, Favas TT, Mishra VN, Pathak A, Singh VK. Generalized morphea coincident with aplastic anemia: a case report. Cureus. 2022;14(1):e20955.","journal-title":"Cureus"},{"issue":"6","key":"1330_CR16","first-page":"1289","volume":"39","author":"X Tan","year":"2022","unstructured":"Tan X, Tian Y, Li Z, Cui S, Wang Z, Zhou Y, et al. Nutritional assessment of patients with aplastic anemia: comparison of four nutritional screening tools. Nutr Hosp. 2022;39(6):1289\u201397.","journal-title":"Nutr Hosp"},{"key":"1330_CR17","doi-asserted-by":"publisher","first-page":"669887","DOI":"10.3389\/fcell.2021.669887","volume":"9","author":"Y Shao","year":"2021","unstructured":"Shao Y, Qi W, Zhang X, Ran N, Liu C, Fu R, et al. Plasma metabolomic and intestinal microbial analyses of patients with severe aplastic anemia. Front Cell Dev Biol. 2021;9:669887.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"1330_CR18","doi-asserted-by":"publisher","first-page":"e04845","DOI":"10.1002\/ccr3.4845","volume":"9","author":"R Sweeney","year":"2021","unstructured":"Sweeney R, Esmail F, Mirza KM, Nand S. Hypercellular bone marrow in aplastic anemia: a case report of two patients. Clin Case Rep. 2021;9(11):e04845.","journal-title":"Clin Case Rep"},{"key":"1330_CR19","doi-asserted-by":"publisher","first-page":"4234116","DOI":"10.1155\/2022\/4234116","volume":"2022","author":"J Mo","year":"2022","unstructured":"Mo J, Da X, Li Q, Huang J, Lu L, Lu H. The study of exosomes-encapsulated mPEG-PLGA polymer drug-loaded particles for targeted therapy of liver cancer. J Oncol. 2022;2022:4234116.","journal-title":"J Oncol"},{"key":"1330_CR20","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.2147\/IJN.S472038","volume":"19","author":"M Qiu","year":"2024","unstructured":"Qiu M, Zou J, Yang Z, Yang D, Wang R, Guo H. Strategies for targeting peptide-modified exosomes and their applications in the lungs. Int J Nanomedicine. 2024;19:8175\u201388.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1330_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12951-023-02176-8","volume":"21","author":"Z Cui","year":"2023","unstructured":"Cui Z, Amevor FK, Zhao X, Mou C, Pang J, Peng X, et al. Potential therapeutic effects of milk-derived exosomes on intestinal diseases. J Nanobiotechnol. 2023;21(1):496.","journal-title":"J Nanobiotechnol"},{"key":"1330_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/bios15030141","author":"J Liu","year":"2025","unstructured":"Liu J, Srivastava S, Li T, Moujane F, Lee JY, Chen Y, et al. On the feasibility of SERS-based monitoring of drug loading efficiency in exosomes for targeted delivery. Biosensors. 2025.","journal-title":"Biosensors"},{"key":"1330_CR23","doi-asserted-by":"publisher","first-page":"728616","DOI":"10.3389\/fcell.2022.728616","volume":"10","author":"L Chen","year":"2022","unstructured":"Chen L, Wang L, Zhu L, Xu Z, Liu Y, Li Z, et al. Exosomes as drug carriers in anti-cancer therapy. Front Cell Dev Biol. 2022;10:728616.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1330_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/1061186X.2022.2162059","volume":"31","author":"Q Feng","year":"2023","unstructured":"Feng Q, Zhang Y, Fang Y, Kong X, He Z, Ji J, et al. Research progress of exosomes as drug carriers in cancer and inflammation. J Drug Target. 2023;31(4):335\u201353.","journal-title":"J Drug Target"},{"issue":"2","key":"1330_CR25","first-page":"61","volume":"76","author":"XM Xi","year":"2021","unstructured":"Xi XM, Xia SJ, Lu R. Drug loading techniques for exosome-based drug delivery systems. Pharmazie. 2021;76(2):61\u20137.","journal-title":"Pharmazie"},{"key":"1330_CR26","doi-asserted-by":"publisher","first-page":"216093","DOI":"10.1016\/j.canlet.2023.216093","volume":"558","author":"R Raguraman","year":"2023","unstructured":"Raguraman R, Bhavsar D, Kim D, Ren X, Sikavitsas V, Munshi A, et al. Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett. 2023;558:216093.","journal-title":"Cancer Lett"},{"key":"1330_CR27","doi-asserted-by":"publisher","first-page":"797359","DOI":"10.3389\/fbioe.2021.797359","volume":"9","author":"D Rao","year":"2021","unstructured":"Rao D, Huang D, Sang C, Zhong T, Zhang Z, Tang Z. Advances in mesenchymal stem cell-derived exosomes as drug delivery vehicles. Front Bioeng Biotechnol. 2021;9:797359.","journal-title":"Front Bioeng Biotechnol"},{"key":"1330_CR28","doi-asserted-by":"publisher","first-page":"865682","DOI":"10.3389\/fbioe.2022.865682","volume":"10","author":"X Wang","year":"2022","unstructured":"Wang X, Zhao X, Zhong Y, Shen J, An W. Biomimetic exosomes: a new generation of drug delivery system. Front Bioeng Biotechnol. 2022;10:865682.","journal-title":"Front Bioeng Biotechnol"},{"key":"1330_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10010104","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei Y, Liao H, Fu H, Yang X, Xiang Q, et al. Plant exosome-like nanoparticles as biological shuttles for transdermal drug delivery. Bioengineering. 2023.\u00a0","journal-title":"Bioengineering"},{"issue":"6","key":"1330_CR30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.2174\/1567201817666200817112503","volume":"18","author":"S Li","year":"2021","unstructured":"Li S, Tang Y, Dou Y. The potential of milk-derived exosomes for drug delivery. Curr Drug Deliv. 2021;18(6):688\u201399.","journal-title":"Curr Drug Deliv"},{"key":"1330_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jconrel.2023.10.031","volume":"364","author":"Y Xue","year":"2023","unstructured":"Xue Y, Riva N, Zhao L, Shieh JS, Chin YT, Gatt A, et al. Recent advances of exosomes in soft tissue injuries in sports medicine: a critical review on biological and biomaterial applications. J Control Release. 2023;364:90\u2013108.","journal-title":"J Control Release"},{"key":"1330_CR32","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.addr.2025.115522","volume":"218","author":"A Kostyusheva","year":"2025","unstructured":"Kostyusheva A, Romano E, Yan N, Lopus M, Zamyatnin AA Jr., Parodi A. Breaking barriers in targeted therapy: advancing exosome isolation, engineering, and imaging. Adv Drug Deliv Rev. 2025;218:115522.","journal-title":"Adv Drug Deliv Rev"},{"key":"1330_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/life11080784","author":"B Panda","year":"2021","unstructured":"Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal stem cell-derived exosomes as an emerging paradigm for regenerative therapy and nano-medicine: a comprehensive review. Life. 2021.","journal-title":"Life"},{"key":"1330_CR34","doi-asserted-by":"publisher","first-page":"155810","DOI":"10.1016\/j.phymed.2024.155810","volume":"132","author":"Q Nian","year":"2024","unstructured":"Nian Q, Liu R, Zeng J. Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products. Phytomedicine. 2024;132:155810.","journal-title":"Phytomedicine"},{"issue":"11","key":"1330_CR35","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1002\/ptr.8322","volume":"38","author":"J Liang","year":"2024","unstructured":"Liang J, Zhu Y, Liu S, Kuang B, Tian Z, Zhang L, et al. Progress of exosomal microRNAs and traditional Chinese medicine monomers in neurodegenerative diseases. Phytother Res. 2024;38(11):5323\u201349.","journal-title":"Phytother Res"},{"issue":"3","key":"1330_CR36","doi-asserted-by":"publisher","first-page":"e2200678","DOI":"10.1002\/jssc.202200678","volume":"46","author":"Y Hu","year":"2023","unstructured":"Hu Y, Sun H, Yan G, Zhang X, Guan Y, Li D, et al. Combination of ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry and network pharmacology to reveal the mechanism of Shengyu Decoction for treating anemia. J Sep Sci. 2023;46(3):e2200678.","journal-title":"J Sep Sci"},{"key":"1330_CR37","doi-asserted-by":"publisher","first-page":"730776","DOI":"10.3389\/fphar.2021.730776","volume":"12","author":"ML Chiu","year":"2021","unstructured":"Chiu ML, Hsu YL, Chen CJ, Li TM, Chiou JS, Tsai FJ, et al. Chinese herbal medicine therapy reduces the risks of overall and anemia-related mortalities in patients with aplastic anemia: a nationwide retrospective study in Taiwan. Front Pharmacol. 2021;12:730776.","journal-title":"Front Pharmacol"},{"issue":"15","key":"1330_CR38","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1021\/acs.jcim.3c00365","volume":"63","author":"X Liu","year":"2023","unstructured":"Liu X, Liu J, Fu B, Chen R, Jiang J, Chen H, et al. DCABM-TCM: a database of constituents absorbed into the blood and metabolites of traditional Chinese medicine. J Chem Inf Model. 2023;63(15):4948\u201359.","journal-title":"J Chem Inf Model"},{"key":"1330_CR39","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1016\/j.csbj.2023.11.030","volume":"21","author":"D Yang","year":"2023","unstructured":"Yang D, Zhu Z, Yao Q, Chen C, Chen F, Gu L, et al. ccTCM: A quantitative component and compound platform for promoting the research of traditional Chinese medicine. Comput Struct Biotechnol J. 2023;21:5807\u201317.","journal-title":"Comput Struct Biotechnol J"},{"key":"1330_CR40","doi-asserted-by":"publisher","first-page":"115235","DOI":"10.1016\/j.jpba.2023.115235","volume":"226","author":"XY Liu","year":"2023","unstructured":"Liu XY, Zhang YB, Yang XW, Wu XW, Yang YF, Xu W, et al. Biological analysis of constituents in Spatholobi Caulis by UFLC-MS\/MS: enhanced quantification and application to permeability properties study in Caco-2 cell monolayer model. J Pharm Biomed Anal. 2023;226:115235.","journal-title":"J Pharm Biomed Anal"},{"key":"1330_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27227789","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wu D, Wang Y, Chen Z. Exosomes as novel delivery systems for application in traditional Chinese medicine. Molecules. 2022.","journal-title":"Molecules"},{"key":"1330_CR42","doi-asserted-by":"publisher","first-page":"844782","DOI":"10.3389\/fphar.2022.844782","volume":"13","author":"C Mo","year":"2022","unstructured":"Mo C, Zhao J, Liang J, Wang H, Chen Y, Huang G. Exosomes: a novel insight into traditional Chinese medicine. Front Pharmacol. 2022;13:844782.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1330_CR43","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2174\/0115672018305953240606063911","volume":"22","author":"W Fu","year":"2025","unstructured":"Fu W, Zhang P, Wang W, Du M, Ni R, Sun Y. Frontiers of plant-derived exosomes from research methods to pharmaceutical applications in plant-based therapeutics. Curr Drug Deliv. 2025;22(5):522\u201336.","journal-title":"Curr Drug Deliv"},{"key":"1330_CR44","doi-asserted-by":"publisher","first-page":"11863","DOI":"10.3389\/jpps.2023.11863","volume":"26","author":"J Guan","year":"2023","unstructured":"Guan J, Zhao Y, Wang T, Fu R. Traditional Chinese medicine for treating aplastic anemia. J Pharm Pharm Sci. 2023;26:11863.","journal-title":"J Pharm Pharm Sci"},{"key":"1330_CR45","doi-asserted-by":"publisher","first-page":"743189","DOI":"10.3389\/fonc.2021.743189","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu P, Tan H, Chen X, Wang Q, Chen T. Exosomes as smart nanoplatforms for diagnosis and therapy of cancer. Front Oncol. 2021;11:743189.","journal-title":"Front Oncol"},{"key":"1330_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ph18071005","author":"TU Rehman","year":"2025","unstructured":"Rehman TU, Li H, Martuscelli M, Aiello F, Esposito L, Ashraf K, et al. Plant-derived exosomes: nano-inducers of cross-kingdom regulations. Pharmaceuticals (Basel). 2025.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1330_CR47","doi-asserted-by":"publisher","first-page":"110316","DOI":"10.1016\/j.fsi.2025.110316","volume":"162","author":"C Nikapitiya","year":"2025","unstructured":"Nikapitiya C, Jayathilaka E, Edirisinghe SL, Oh C, De Zoysa M. Characterization, microRNA profiling, and immunomodulatory role of plasma-derived exosomes from olive flounder (Paralichthys olivaceus) in response to viral hemorrhagic septicemia virus. Fish Shellfish Immunol. 2025;162:110316.","journal-title":"Fish Shellfish Immunol"},{"key":"1330_CR48","doi-asserted-by":"publisher","first-page":"108777","DOI":"10.1016\/j.fsi.2023.108777","volume":"137","author":"E Jayathilaka","year":"2023","unstructured":"Jayathilaka E, Edirisinghe SL, Oh C, Nikapitiya C, De Zoysa M. Exosomes from bacteria (Streptococcus parauberis) challenged olive flounder (Paralichthys olivaceus): isolation, molecular characterization, wound healing, and regeneration activities. Fish Shellfish Immunol. 2023;137:108777.","journal-title":"Fish Shellfish Immunol"},{"key":"1330_CR49","doi-asserted-by":"publisher","first-page":"102427","DOI":"10.1016\/j.tice.2024.102427","volume":"88","author":"F Rahmatinejad","year":"2024","unstructured":"Rahmatinejad F, Kharat Z, Jalili H, Renani MK, Mobasheri H. Comparison of morphology, protein concentration, and size distribution of bone marrow and Wharton\u2019s jelly-derived mesenchymal stem cells exosomes isolated by ultracentrifugation and polymer-based precipitation techniques. Tissue Cell. 2024;88:102427.","journal-title":"Tissue Cell"},{"key":"1330_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/mi12101182","author":"W Chen","year":"2021","unstructured":"Chen W, Xie Y, Chang Y, Xu Y, Zhao M, Deng P, et al. A portable device for simple exosome separation from biological samples. Micromachines. 2021.","journal-title":"Micromachines"},{"issue":"2","key":"1330_CR51","doi-asserted-by":"publisher","first-page":"025705","DOI":"10.1088\/1361-6528\/abba58","volume":"32","author":"Y Choi","year":"2021","unstructured":"Choi Y, Kim SM, Heo Y, Lee G, Kang JY, Yoon DS. Nanoelectrical characterization of individual exosomes secreted by Abeta(42)-ingested cells using electrostatic force microscopy. Nanotechnology. 2021;32(2):025705.","journal-title":"Nanotechnology"},{"issue":"42","key":"1330_CR52","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.1021\/acs.langmuir.0c02491","volume":"36","author":"K Sakai-Kato","year":"2020","unstructured":"Sakai-Kato K, Yoshida K, Takechi-Haraya Y, Izutsu KI. Physicochemical characterization of liposomes that mimic the lipid composition of exosomes for effective intracellular trafficking. Langmuir. 2020;36(42):12735\u201344.","journal-title":"Langmuir"},{"key":"1330_CR53","doi-asserted-by":"publisher","first-page":"1447953","DOI":"10.3389\/fmolb.2024.1447953","volume":"11","author":"P Ubanako","year":"2024","unstructured":"Ubanako P, Mirza S, Ruff P, Penny C. Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges. Front Mol Biosci. 2024;11:1447953.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"1330_CR54","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56(4):836\u201349.","journal-title":"Exp Mol Med"},{"key":"1330_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-025-05073-7","author":"S Aryal","year":"2025","unstructured":"Aryal S. Exosome-based therapies in dermatology. Aesthet Plast Surg. 2025.","journal-title":"Aesthet Plast Surg"},{"issue":"2","key":"1330_CR56","first-page":"100797","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y, Xing L, Wang L, Liu X, Wu L, Ni M, et al. Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs. Asian J Pharm Sci. 2023;18(2):100797.","journal-title":"Asian J Pharm Sci"},{"key":"1330_CR57","doi-asserted-by":"publisher","first-page":"596132","DOI":"10.3389\/fonc.2020.596132","volume":"10","author":"K Feng","year":"2020","unstructured":"Feng K, Ma R, Zhang L, Li H, Tang Y, Du G, et al. The role of exosomes in thyroid cancer and their potential clinical application. Front Oncol. 2020;10:596132.","journal-title":"Front Oncol"},{"issue":"5","key":"1330_CR58","first-page":"455","volume":"43","author":"YH Xing","year":"2025","unstructured":"Xing YH, Ren XS, Li DH, Liu L. [Exosome separation and analysis based on microfluidics technology and its clinical applications]. Se Pu. 2025;43(5):455\u201371.","journal-title":"Se Pu"},{"issue":"11","key":"1330_CR59","doi-asserted-by":"publisher","first-page":"17047","DOI":"10.1021\/acsnano.1c03469","volume":"15","author":"S Hassanpour Tamrin","year":"2021","unstructured":"Hassanpour Tamrin S, Sanati Nezhad A, Sen A. Label-free isolation of exosomes using microfluidic technologies. ACS Nano. 2021;15(11):17047\u201379.","journal-title":"ACS Nano"},{"issue":"1","key":"1330_CR60","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13287-023-03496-0","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang S, Huo J, Liu Y, Chen L, Ren X, Li X, et al. Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia. Stem Cell Res Ther. 2023;14(1):285.","journal-title":"Stem Cell Res Ther"},{"key":"1330_CR61","doi-asserted-by":"publisher","first-page":"117386","DOI":"10.1016\/j.biopha.2024.117386","volume":"179","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liang Y, Luo D, Li P, Chen Y, Fu X, et al. Advantages and disadvantages of various hydrogel scaffold types: a research to improve the clinical conversion rate of loaded MSCs-Exos hydrogel scaffolds. Biomed Pharmacother. 2024;179:117386.","journal-title":"Biomed Pharmacother"},{"key":"1330_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cells13231956","author":"S Yadav","year":"2024","unstructured":"Yadav S, Maity P, Kapat K. The opportunities and challenges of mesenchymal stem cells-derived exosomes in theranostics and regenerative medicine. Cells. 2024.\u00a0","journal-title":"Cells"},{"key":"1330_CR63","doi-asserted-by":"publisher","first-page":"1238789","DOI":"10.3389\/fimmu.2023.1238789","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Wang T, Xue Y, Zhan B, Lai Z, Huang W, et al. Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases. Front Immunol. 2023;14:1238789.","journal-title":"Front Immunol"},{"issue":"1","key":"1330_CR64","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-023-03417-1","volume":"14","author":"C He","year":"2023","unstructured":"He C, Yang C, Zeng Q, Liu Z, Wang F, Chen Q, et al. Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy. Stem Cell Res Ther. 2023;14(1):224.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1330_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13287-023-03263-1","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Li K, Jiang J, Jiang L, Ma X, Ai F, et al. Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3 + Treg cells and gut microbiota. Stem Cell Res Ther. 2023;14(1):43.","journal-title":"Stem Cell Res Ther"},{"issue":"14","key":"1330_CR66","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3390\/cells11142252","volume":"11","author":"VF Gonzaga","year":"2022","unstructured":"Gonzaga VF, Wenceslau CV, Vieira DP, Policiquio BO, Khalil C, Araldi RP, et al. Therapeutic Potential of Human Immature Dental Pulp Stem Cells Observed in Mouse Model for Acquired Aplastic Anemia. Cells. 2022;11(14):2252.","journal-title":"Cells."},{"issue":"8","key":"1330_CR67","first-page":"1693","volume":"110","author":"JH Oved","year":"2025","unstructured":"Oved JH, Bacigalupo A, DeZern AE. Towards graft-versus-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia. Haematologica. 2025;110(8):1693\u2013701.","journal-title":"Haematologica"},{"key":"1330_CR68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149856","author":"Y Guan","year":"2022","unstructured":"Guan Y, Hasipek M, Jiang D, Tiwari AD, Grabowski DR, Pagliuca S, et al. Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia. J Clin Invest. 2022.\u00a0","journal-title":"J Clin Invest"},{"issue":"1","key":"1330_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13643-024-02515-2","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li J, Li X, Geng Q, Xie Y, Zhang G, et al. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis. Syst Rev. 2024;13(1):101.","journal-title":"Syst Rev"},{"issue":"1","key":"1330_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood.2020008966","volume":"138","author":"C Zhu","year":"2021","unstructured":"Zhu C, Lian Y, Wang C, Wu P, Li X, Gao Y, et al. Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia. Blood. 2021;138(1):23\u201333.","journal-title":"Blood"},{"issue":"26","key":"1330_CR71","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1182\/blood.2021012895","volume":"138","author":"Y Zaimoku","year":"2021","unstructured":"Zaimoku Y, Patel BA, Adams SD, Shalhoub R, Groarke EM, Lee AAC, et al. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia. Blood. 2021;138(26):2799\u2013809.","journal-title":"Blood"},{"issue":"1","key":"1330_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-021-02410-z","volume":"22","author":"J Chen","year":"2022","unstructured":"Chen J, Zhang Y, Chen X, Pang A, Zhao Y, Liu L, et al. Comparison of porcine ALG and rabbit ATG on outcomes of HLA-haploidentical hematopoietic stem cell transplantation for patients with acquired aplastic anemia. Cancer Cell Int. 2022;22(1):89.","journal-title":"Cancer Cell Int"},{"key":"1330_CR73","doi-asserted-by":"publisher","first-page":"1146997","DOI":"10.3389\/fimmu.2023.1146997","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yang W, Yang D, Wei J, Zhang P, Feng S, et al. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia. Front Immunol. 2023;14:1146997.","journal-title":"Front Immunol"},{"issue":"6","key":"1330_CR74","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41375-022-01549-6","volume":"36","author":"N Tsuji","year":"2022","unstructured":"Tsuji N, Hosokawa K, Urushihara R, Tanabe M, Zaimoku Y, Katagiri T, et al. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15. Leukemia. 2022;36(6):1666\u201375.","journal-title":"Leukemia"},{"key":"1330_CR75","doi-asserted-by":"publisher","first-page":"1378432","DOI":"10.3389\/fimmu.2024.1378432","volume":"15","author":"A Piekarska","year":"2024","unstructured":"Piekarska A, Pawelec K, Szmigielska-Kaplon A, Ussowicz M. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults. Front Immunol. 2024;15:1378432.","journal-title":"Front Immunol"},{"key":"1330_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221908","author":"AI Dorofeeva","year":"2024","unstructured":"Dorofeeva AI, Shipounova IN, Nikiforova KA, Galtseva IV, Kuzmina LA, Luchkin AV, et al. PDGF-BB deficiency in the blood serum from aplastic anemia patients affects bone marrow-derived multipotent mesenchymal stromal cells. Cells. 2024.","journal-title":"Cells"},{"issue":"1","key":"1330_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17.","journal-title":"Signal Transduct Target Ther"},{"key":"1330_CR78","doi-asserted-by":"publisher","first-page":"4539453","DOI":"10.1155\/2021\/4539453","volume":"2021","author":"M Shen","year":"2021","unstructured":"Shen M, Chen T. Mesenchymal stem cell-derived exosomes and their potential agents in hematological diseases. Oxid Med Cell Longev. 2021;2021:4539453.","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"1330_CR79","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3324\/haematol.2021.280292","volume":"107","author":"P Dong","year":"2022","unstructured":"Dong P, Chen L, Wu H, Huo J, Jiang Z, Shao Y, et al. Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia. Haematologica. 2022;107(12):2834\u201345.","journal-title":"Haematologica"},{"issue":"8","key":"1330_CR80","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1182\/blood.2025028723","volume":"146","author":"ES Pool","year":"2025","unstructured":"Pool ES, Luk SJ, Ijsselsteijn ME, van Unen V, de Miranda N, Falkenburg JHF, et al. Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia. Blood. 2025;146(8):951\u201363.","journal-title":"Blood"},{"issue":"1","key":"1330_CR81","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.medj.2021.12.003","volume":"3","author":"JM Rosenberg","year":"2022","unstructured":"Rosenberg JM, Peters JM, Hughes T, Lareau CA, Ludwig LS, Massoth LR, et al. JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia. Med. 2022;3(1):42-57.e5.","journal-title":"Med"},{"issue":"6","key":"1330_CR82","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41375-025-02595-6","volume":"39","author":"R Takahashi","year":"2025","unstructured":"Takahashi R, Takahashi H, Seoka L, Iwasaki H, Takamatsu H, Imi T, et al. Interferon-gamma-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia. Leukemia. 2025;39(6):1490\u2013502.","journal-title":"Leukemia"},{"issue":"1","key":"1330_CR83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13287-024-04125-0","volume":"16","author":"A Mohseni","year":"2025","unstructured":"Mohseni A, Salehi F, Rostami S, Hadiloo K, Hashemi M, Baridjavadi Z, et al. Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies. Stem Cell Res Ther. 2025;16(1):6.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"1330_CR84","doi-asserted-by":"publisher","first-page":"qiaf073","DOI":"10.1093\/jleuko\/qiaf073","volume":"117","author":"J Glass","year":"2025","unstructured":"Glass J, Feng X, Chen J, Durrani J, Wu Z, Gao S, et al. Macrophage polarization, inflammatory monocytes, and impaired MDSCs are associated with murine and human immune aplastic anemia. J Leukoc Biol. 2025;117(6):qiaf073.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1330_CR85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/bloodadvances.2022007254","volume":"7","author":"X Feng","year":"2023","unstructured":"Feng X, Kim J, Gonzalez-Matias G, Aggarwal N, Manley AL, Wu Z, et al. Granulocytic myeloid-derived suppressor cells to prevent and treat murine immune-mediated bone marrow failure. Blood Adv. 2023;7(1):73\u201386.","journal-title":"Blood Adv"},{"key":"1330_CR86","doi-asserted-by":"publisher","first-page":"907808","DOI":"10.3389\/fimmu.2022.907808","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Liu J, Wang M, Zhao F, Ge M, Liu L, et al. Levamisole suppresses CD4(+) T-cell proliferation and antigen-presenting cell activation in aplastic anemia by regulating the JAK\/STAT and TLR signaling pathways. Front Immunol. 2022;13:907808.","journal-title":"Front Immunol"},{"key":"1330_CR87","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2025.2479066","author":"Y Han","year":"2025","unstructured":"Han Y, Guo X, Ji Z, Guo Y, Ma W, Du H, et al. Colon health benefits of plant-derived exosome-like nanoparticles via modulating gut microbiota and immunity. Crit Rev Food Sci Nutr. 2025.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1330_CR88","doi-asserted-by":"publisher","first-page":"116543","DOI":"10.1016\/j.biopha.2024.116543","volume":"174","author":"C Bai","year":"2024","unstructured":"Bai C, Liu J, Zhang X, Li Y, Qin Q, Song H, et al. Research status and challenges of plant-derived exosome-like nanoparticles. Biomed Pharmacother. 2024;174:116543.","journal-title":"Biomed Pharmacother"},{"key":"1330_CR89","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.2147\/IJN.S540094","volume":"20","author":"Y Song","year":"2025","unstructured":"Song Y, Feng N, Yu Q, Li Y, Meng M, Yang X, et al. Exosomes in disease therapy: plant-derived exosome-like nanoparticles current status, challenges, and future prospects. Int J Nanomedicine. 2025;20:10613\u201344.","journal-title":"Int J Nanomedicine"},{"issue":"23","key":"1330_CR90","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1080\/10408398.2024.2388888","volume":"65","author":"C Wei","year":"2025","unstructured":"Wei C, Zhang M, Cheng J, Tian J, Yang G, Jin Y. Plant-derived exosome-like nanoparticles - from laboratory to factory, a landscape of application, challenges and prospects. Crit Rev Food Sci Nutr. 2025;65(23):4510\u201328.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1330_CR91","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.2147\/IJN.S543947","volume":"20","author":"J Chi","year":"2025","unstructured":"Chi J, Wang X, Song Y, Wang J, Guo L, Wang R, et al. Emerging plant-derived exosome-like particles reveal key therapeutic benefits. A comprehensive review of evidence. Int J Nanomed. 2025;20:12393\u2013411.","journal-title":"Int J Nanomed"},{"key":"1330_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115007","volume":"165","author":"FS Qiu","year":"2023","unstructured":"Qiu FS, Wang JF, Guo MY, Li XJ, Shi CY, Wu F, et al. Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis. Biomed Pharmacother. 2023;165:115007.","journal-title":"Biomed Pharmacother"},{"key":"1330_CR93","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.2147\/IJN.S370784","volume":"17","author":"DF Li","year":"2022","unstructured":"Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, et al. Extracellular vesicles: the next generation theranostic nanomedicine for inflammatory bowel disease. Int J Nanomed. 2022;17:3893\u2013911.","journal-title":"Int J Nanomed"},{"issue":"5","key":"1330_CR94","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jgr.2023.01.004","volume":"47","author":"J Kim","year":"2023","unstructured":"Kim J, Zhang S, Zhu Y, Wang R, Wang J. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines. J Ginseng Res. 2023;47(5):627\u201337.","journal-title":"J Ginseng Res"},{"issue":"37","key":"1330_CR95","doi-asserted-by":"publisher","first-page":"23344","DOI":"10.1021\/acs.jafc.5c04523","volume":"73","author":"M Zhan","year":"2025","unstructured":"Zhan M, Cai Y, Zhao C, Chen B, Wang X, Shen P, et al. Citrus exosome-like nanoparticles reversed high-fat diet-induced microbiota dysbiosis and associated short-chain fatty acid production. J Agric Food Chem. 2025;73(37):23344\u201356.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"1330_CR96","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12951-025-03602-9","volume":"23","author":"KM Tembo","year":"2025","unstructured":"Tembo KM, Wang X, Bolideei M, Liu Q, Baboni F, Mehran MJ, et al. Exploring the bioactivity of MicroRNAs originated from plant-derived exosome-like nanoparticles (PELNs): current perspectives. J Nanobiotechnol. 2025;23(1):563.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1330_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","volume":"29","author":"HA Dad","year":"2021","unstructured":"Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther. 2021;29(1):13\u201331.","journal-title":"Mol Ther"},{"key":"1330_CR98","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.2147\/IJN.S420748","volume":"18","author":"N Mu","year":"2023","unstructured":"Mu N, Li J, Zeng L, You J, Li R, Qin A, et al. Plant-derived exosome-like nanovesicles: current progress and prospects. Int J Nanomed. 2023;18:4987\u20135009.","journal-title":"Int J Nanomed"},{"key":"1330_CR99","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2147\/IJN.S448905","volume":"19","author":"H Feng","year":"2024","unstructured":"Feng H, Yue Y, Zhang Y, Liang J, Liu L, Wang Q, et al. Plant-derived exosome-like nanoparticles: emerging nanosystems for enhanced tissue engineering. Int J Nanomed. 2024;19:1189\u2013204.","journal-title":"Int J Nanomed"},{"issue":"7","key":"1330_CR100","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1039\/D4TB02394C","volume":"13","author":"C Gao","year":"2025","unstructured":"Gao C, Chen Y, Wen X, Han R, Qin Y, Li S, et al. Plant-derived exosome-like nanoparticles in tissue repair and regeneration. J Mater Chem B. 2025;13(7):2254\u201371.","journal-title":"J Mater Chem B"},{"issue":"11","key":"1330_CR101","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1002\/bit.28821","volume":"121","author":"RE Kilgore","year":"2024","unstructured":"Kilgore RE, Moore BD, Sripada SA, Chu W, Shastry S, Barbieri E, et al. Peptide ligands for the universal purification of exosomes by affinity chromatography. Biotechnol Bioeng. 2024;121(11):3484\u2013501.","journal-title":"Biotechnol Bioeng"},{"key":"1330_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210194","author":"AM Timofeeva","year":"2023","unstructured":"Timofeeva AM, Paramonik AP, Sedykh SS, Nevinsky GA. Milk exosomes: next-generation agents for delivery of anticancer drugs and therapeutic nucleic acids. Int J Mol Sci. 2023.\u00a0","journal-title":"Int J Mol Sci"},{"key":"1330_CR103","doi-asserted-by":"publisher","first-page":"1363742","DOI":"10.3389\/fbioe.2024.1363742","volume":"12","author":"JL Pang","year":"2024","unstructured":"Pang JL, Shao H, Xu XG, Lin ZW, Chen XY, Chen JY, et al. Targeted drug delivery of engineered mesenchymal stem\/stromal-cell-derived exosomes in cardiovascular disease: recent trends and future perspectives. Front Bioeng Biotechnol. 2024;12:1363742.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"1330_CR104","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/pharmaceutics15010066","volume":"15","author":"A Akbari","year":"2022","unstructured":"Akbari A, Nazari-Khanamiri F, Ahmadi M, Shoaran M, Rezaie J. Engineered exosomes for tumor-targeted drug delivery: a focus on genetic and chemical functionalization. Pharmaceutics. 2022;15(1):66.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1330_CR105","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12964-025-02268-y","volume":"23","author":"SG Gabaran","year":"2025","unstructured":"Gabaran SG, Ghasemzadeh N, Rahnama M, Karatas E, Akbari A, Rezaie J. Functionalized exosomes for targeted therapy in cancer and regenerative medicine: genetic, chemical, and physical modifications. Cell Commun Signal. 2025;23(1):265.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"1330_CR106","doi-asserted-by":"publisher","first-page":"e2020241118","DOI":"10.1073\/pnas.2020241118","volume":"118","author":"S Lathwal","year":"2021","unstructured":"Lathwal S, Yerneni SS, Boye S, Muza UL, Takahashi S, Sugimoto N, et al. Engineering exosome polymer hybrids by atom transfer radical polymerization. Proc Natl Acad Sci USA. 2021;118(2):e2020241118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1330_CR107","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4103\/NRR.NRR-D-24-00720","volume":"21","author":"H Chen","year":"2026","unstructured":"Chen H, Li N, Cai Y, Ma C, Ye Y, Shi X, et al. Exosomes in neurodegenerative diseases: Therapeutic potential and modification methods. Neural Regen Res. 2026;21(2):478\u201390.","journal-title":"Neural Regen Res"},{"issue":"1","key":"1330_CR108","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12951-024-02517-1","volume":"22","author":"Z Lin","year":"2024","unstructured":"Lin Z, Xu G, Lu X, Liu S, Zou F, Ma X, et al. Chondrocyte-targeted exosome-mediated delivery of Nrf2 alleviates cartilaginous endplate degeneration by modulating mitochondrial fission. J Nanobiotechnology. 2024;22(1):281.","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"1330_CR109","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.1021\/acsabm.5c00955","volume":"8","author":"R Vasave","year":"2025","unstructured":"Vasave R, Bhawale R, Khan O, Pardhi E, Rajana N, Kumari NU, et al. Translational potential of surface engineered extracellular vesicles as theranostic nanocarriers in cancer management: recent developments from bench to bedside. ACS Appl Bio Mater. 2025;8(8):6647\u201375.","journal-title":"ACS Appl Bio Mater"},{"issue":"4","key":"1330_CR110","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s13346-024-01710-x","volume":"15","author":"SA Vahab","year":"2025","unstructured":"Vahab SA, V VK, Kumar VS. Exosome-based drug delivery systems for enhanced neurological therapeutics. Drug Deliv Transl Res. 2025;15(4):1121\u201338.","journal-title":"Drug Deliv Transl Res"},{"key":"1330_CR111","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2025.2541789","author":"Y Li","year":"2025","unstructured":"Li Y, Meng D, Cheng Y, Sun Y, Dong Y, Shi J, et al. Prospects of engineered exosomes in clinical applications: a review. Drug Dev Ind Pharm. 2025.\u00a0","journal-title":"Drug Dev Ind Pharm"},{"issue":"46","key":"1330_CR112","doi-asserted-by":"publisher","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","volume":"8","author":"L Huang","year":"2023","unstructured":"Huang L, Wu E, Liao J, Wei Z, Wang J, Chen Z. Research advances of engineered exosomes as drug delivery carrier. ACS Omega. 2023;8(46):43374\u201387.","journal-title":"ACS Omega"},{"issue":"1","key":"1330_CR113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12015-020-10002-z","volume":"17","author":"Pinky","year":"2021","unstructured":"Pinky, Gupta S, Krishnakumar V, Sharma Y, Dinda AK, Mohanty S. Mesenchymal stem cell derived exosomes: a nano platform for therapeutics and drug delivery in combating COVID-19. Stem Cell Rev Rep. 2021;17(1):33\u201343.","journal-title":"Stem Cell Rev Rep"},{"key":"1330_CR114","doi-asserted-by":"publisher","first-page":"1001417","DOI":"10.3389\/fphar.2022.1001417","volume":"13","author":"F Yang","year":"2022","unstructured":"Yang F, Wang M, Guan X. Exosomes and mimics as novel delivery platform for cancer therapy. Front Pharmacol. 2022;13:1001417.","journal-title":"Front Pharmacol"},{"key":"1330_CR115","doi-asserted-by":"publisher","first-page":"123499","DOI":"10.1016\/j.lfs.2025.123499","volume":"368","author":"OM Saka","year":"2025","unstructured":"Saka OM, Dora DD, Kibar G, Tevlek A. Expanding the role of exosomes in drug, biomolecule, and nanoparticle delivery. Life Sci. 2025;368:123499.","journal-title":"Life Sci"},{"issue":"9","key":"1330_CR116","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/1061186X.2021.1894436","volume":"29","author":"S Modani","year":"2021","unstructured":"Modani S, Tomar D, Tangirala S, Sriram A, Mehra NK, Kumar R, et al. An updated review on exosomes: biosynthesis to clinical applications. J Drug Target. 2021;29(9):925\u201340.","journal-title":"J Drug Target"},{"issue":"2","key":"1330_CR117","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1021\/acsami.3c10350","volume":"16","author":"MD Hade","year":"2024","unstructured":"Hade MD, Suire CN, Suo Z. Significant enhancement of fibroblast migration, invasion, and proliferation by exosomes loaded with human fibroblast growth factor 1. ACS Appl Mater Interfaces. 2024;16(2):1969\u201384.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"1330_CR118","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/cells14030202","volume":"14","author":"CR Harrell","year":"2025","unstructured":"Harrell CR, Volarevic A, Djonov V, Volarevic V. Mesenchymal stem-cell-derived exosomes as novel drug carriers in anti-cancer treatment: a myth or reality? Cells. 2025;14(3):202.","journal-title":"Cells"},{"issue":"7","key":"1330_CR119","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/cancers13071635","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang X, He L, Huang X, Zhang S, Cao W, Che F, et al. Recent progress of exosomes in multiple myeloma: pathogenesis, diagnosis, prognosis and therapeutic strategies. Cancers (Basel). 2021;13(7):1635.","journal-title":"Cancers (Basel)"},{"key":"1330_CR120","doi-asserted-by":"publisher","first-page":"109994","DOI":"10.1016\/j.abb.2024.109994","volume":"756","author":"A Ramezani","year":"2024","unstructured":"Ramezani A, Tafazoli A, Salimi F, Ghavami M, Arjmandi H, Khalesi B, et al. Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: opportunities and challenges. Arch Biochem Biophys. 2024;756:109994.","journal-title":"Arch Biochem Biophys"},{"issue":"22","key":"1330_CR121","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1039\/D3BM01169K","volume":"11","author":"M Zhang","year":"2023","unstructured":"Zhang M, Wan L, Li R, Li X, Zhu T, Lu H. Engineered exosomes for tissue regeneration: from biouptake, functionalization and biosafety to applications. Biomater Sci. 2023;11(22):7247\u201367.","journal-title":"Biomater Sci"},{"issue":"29","key":"1330_CR122","doi-asserted-by":"publisher","first-page":"18475","DOI":"10.1039\/D2RA02351B","volume":"12","author":"J Lee","year":"2022","unstructured":"Lee J, Lee JH, Chakraborty K, Hwang J, Lee YK. Exosome-based drug delivery systems and their therapeutic applications. RSC Adv. 2022;12(29):18475\u201392.","journal-title":"RSC Adv"},{"issue":"1","key":"1330_CR123","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12951-022-01472-z","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu Q, Zhang X, Huang H, Tang S, Chai Y, et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnol. 2022;20(1):279.","journal-title":"J Nanobiotechnol"},{"key":"1330_CR124","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.biopha.2024.116803","volume":"176","author":"B Wei","year":"2024","unstructured":"Wei B, Huang H, Cao Q, Song X, Zhang Z. Bibliometric and visualized analysis of the applications of exosomes based drug delivery. Biomed Pharmacother. 2024;176:116803.","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"1330_CR125","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.3390\/molecules29153681","volume":"29","author":"M Sedzik","year":"2024","unstructured":"Sedzik M, Rakoczy K, Sleziak J, Kisiel M, Kraska K, Rubin J, et al. Comparative analysis of exosomes and extracellular microvesicles in healing pathways: insights for advancing regenerative therapies. Molecules. 2024;29(15):3681.","journal-title":"Molecules"},{"issue":"5","key":"1330_CR126","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4252\/wjsc.v16.i5.591","volume":"16","author":"JB Wang","year":"2024","unstructured":"Wang JB, Du MW, Zheng Y. Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice via MAPK pathway. World J Stem Cells. 2024;16(5):591\u2013603.","journal-title":"World J Stem Cells"},{"issue":"11","key":"1330_CR127","doi-asserted-by":"publisher","first-page":"900","DOI":"10.4252\/wjsc.v16.i11.900","volume":"16","author":"SH Park","year":"2024","unstructured":"Park SH. Potential of ginsenoside Rg1 to treat aplastic anemia via mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model. World J Stem Cells. 2024;16(11):900\u20135.","journal-title":"World J Stem Cells"},{"issue":"19","key":"1330_CR128","doi-asserted-by":"publisher","first-page":"e38452","DOI":"10.1016\/j.heliyon.2024.e38452","volume":"10","author":"X Tang","year":"2024","unstructured":"Tang X, Xu R, Wang Y, Liu K. Astragalus polysaccharide ameliorates bone marrow haematopoietic failure in mice with aplastic anaemia via the Hippo\/TERT signalling pathway. Heliyon. 2024;10(19):e38452.","journal-title":"Heliyon"},{"key":"1330_CR129","doi-asserted-by":"publisher","first-page":"6792866","DOI":"10.1155\/2022\/6792866","volume":"2022","author":"X Jin","year":"2022","unstructured":"Jin X, Dai G, Xuan L, Zhang M, Jiang H, Sui Y. Effects of sodium chlorophyllin copper on APO-1 expression in bone marrow mesenchymal stem cells of rats with aplastic anaemia. J Immunol Res. 2022;2022:6792866.","journal-title":"J Immunol Res"},{"key":"1330_CR130","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2024.2386126","author":"W Wei","year":"2024","unstructured":"Wei W, Si Y, Li Z, Yin X, Ma G, Shi J, et al. Exploring the potential mechanism of Chinese herbal medicine Fuzi on aplastic anemia based on UHPLC-MS\/MS method combined with network pharmacology and molecular docking. Nat Prod Res. 2024.","journal-title":"Nat Prod Res"},{"issue":"1","key":"1330_CR131","doi-asserted-by":"publisher","first-page":"17385","DOI":"10.1038\/s41598-023-44672-9","volume":"13","author":"M Ye","year":"2023","unstructured":"Ye M, Liu G, Yang Y, Yang H, Ren J, Chen W, et al. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia. Sci Rep. 2023;13(1):17385.","journal-title":"Sci Rep"},{"issue":"3","key":"1330_CR132","doi-asserted-by":"publisher","first-page":"e20220672","DOI":"10.1590\/0001-3765202320220672","volume":"95","author":"NA Liu","year":"2023","unstructured":"Liu NA, Liu JQ, Liu Y, Zhu Q, Zheng D, Li F, et al. Rehmannia Glutinosa polysaccharide regulates bone marrow microenvironment via HIF-1alpha\/NF-kappaB signaling pathway in aplastic anemia mice. An Acad Bras Cienc. 2023;95(3):e20220672.","journal-title":"An Acad Bras Cienc"},{"issue":"1","key":"1330_CR133","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13020-024-00919-9","volume":"19","author":"H Lan","year":"2024","unstructured":"Lan H, Qiu W, Wu J, Hu Z, Zhang X, Zhu L. Formononetin reverses Treg\/Th17 imbalance in immune-mediated bone marrow failure mice by regulating the PI3K\/Akt signaling pathway. Chin Med. 2024;19(1):55.","journal-title":"Chin Med"},{"key":"1330_CR134","doi-asserted-by":"publisher","first-page":"118575","DOI":"10.1016\/j.jep.2024.118575","volume":"335","author":"S Sun","year":"2024","unstructured":"Sun S, Zhang Y, Gu X, Li D, Liu W, Zhang P, et al. Chinese herbal formula, modified Guilu Erxian glue, alleviates apoptosis of hematopoietic stem cells by regulating SLAM-SAP signal pathway in aplastic anemia mice model. J Ethnopharmacol. 2024;335:118575.","journal-title":"J Ethnopharmacol"},{"key":"1330_CR135","doi-asserted-by":"publisher","first-page":"6655848","DOI":"10.1155\/2021\/6655848","volume":"2021","author":"Z Feng","year":"2021","unstructured":"Feng Z, Hu X, Qu W, Zhu X, Lu J, Huang Z, et al. Metabolomics-based clinical efficacy of compound Shenlu granule, a Chinese patent medicine, in the supportive management of aplastic anemia patients: a randomized controlled pilot trial. Evid Based Complement Alternat Med. 2021;2021:6655848.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"10","key":"1330_CR136","doi-asserted-by":"publisher","first-page":"e5963","DOI":"10.1002\/bmc.5963","volume":"38","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang J, Wang B, Gao Y, Lin S, Zhou Y, et al. Integrating network pharmacology and experimental validation to explore the mitophagy-associated pharmacological mechanism of modified shisiwei jianzhong decoction against aplastic anemia. Biomed Chromatogr. 2024;38(10):e5963.","journal-title":"Biomed Chromatogr"},{"key":"1330_CR137","doi-asserted-by":"publisher","first-page":"9456350","DOI":"10.1155\/2020\/9456350","volume":"2020","author":"HQ Pang","year":"2020","unstructured":"Pang HQ, Xu DQ, Tang YP, Zhou GS, Xu HQ, Jin Y, et al. Comparatively evaluating the role of herb pairs containing angelicae sinensis radix in Xin-Sheng-Hua granule by withdrawal analysis. Evid Based Complement Alternat Med. 2020;2020:9456350.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"1330_CR138","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4314\/ahs.v23i2.81","volume":"23","author":"N Yu","year":"2023","unstructured":"Yu N, Huang H, Wu F. Clinical study on combined \u201clanzhou prescription\u201d for the treatment of \u201csyndrome of heat-toxin congestion and excessiveness\u201d in children with acute aplastic anemias. Afr Health Sci. 2023;23(2):709\u201314.","journal-title":"Afr Health Sci"},{"key":"1330_CR139","doi-asserted-by":"publisher","first-page":"1605359","DOI":"10.1155\/2022\/1605359","volume":"2022","author":"N Dong","year":"2022","unstructured":"Dong N, Zhang X, Wu D, Hu Z, Liu W, Deng S, et al. Medication regularity of Traditional Chinese Medicine in the treatment of aplastic anemia based on data mining. Evid Based Complement Alternat Med. 2022;2022:1605359.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"1330_CR140","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1039\/D4TB02062F","volume":"13","author":"D Song","year":"2025","unstructured":"Song D, Zhang J, Hu X, Liu X. Progress in the treatment of Alzheimer\u2019s disease based on nanosized traditional Chinese medicines. J Mater Chem B. 2025;13(5):1548\u201372.","journal-title":"J Mater Chem B"},{"issue":"1","key":"1330_CR141","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12951-023-02165-x","volume":"21","author":"C Qiu","year":"2023","unstructured":"Qiu C, Zhang JZ, Wu B, Xu CC, Pang HH, Tu QC, et al. Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines. J Nanobiotechnol. 2023;21(1):456.","journal-title":"J Nanobiotechnol"},{"key":"1330_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/pca.3381","author":"Y Xie","year":"2024","unstructured":"Xie Y, Shen X, Xu F, Liang X. Research progress of nano-delivery systems for the active ingredients from traditional Chinese medicine. Phytochem Anal. 2024.","journal-title":"Phytochem Anal"},{"issue":"1","key":"1330_CR143","first-page":"78","volume":"13","author":"RN Wang","year":"2021","unstructured":"Wang RN, Zhao HC, Huang JY, Wang HL, Li JS, Lu Y, et al. Challenges and strategies in progress of drug delivery system for traditional Chinese medicine Salviae Miltiorrhizae Radix et Rhizoma (Danshen). Chin Herb Med. 2021;13(1):78\u201389.","journal-title":"Chin Herb Med"},{"key":"1330_CR144","doi-asserted-by":"publisher","first-page":"e10107","DOI":"10.7717\/peerj.10107","volume":"8","author":"W Ren","year":"2020","unstructured":"Ren W, Luo Z, Pan F, Liu J, Sun Q, Luo G, et al. Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure. PeerJ. 2020;8:e10107.","journal-title":"PeerJ"},{"key":"1330_CR145","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jep.2018.07.008","volume":"236","author":"P Wang","year":"2019","unstructured":"Wang P, Li K, Tao Y, Li D, Zhang Y, Xu H, et al. TCM-ADMEpred: a novel strategy for poly-pharmacokinetics prediction of traditional Chinese medicine based on single constituent pharmacokinetics, structural similarity, and mathematical modeling. J Ethnopharmacol. 2019;236:277\u201387.","journal-title":"J Ethnopharmacol"},{"key":"1330_CR146","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.pharmthera.2024.108728","volume":"264","author":"M Li","year":"2024","unstructured":"Li M, Wang Y, Chen Y, Dong L, Liu J, Dong Y, et al. A comprehensive review on pharmacokinetic mechanism of herb-herb\/drug interactions in Chinese herbal formula. Pharmacol Ther. 2024;264:108728.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1330_CR147","first-page":"700","volume":"23","author":"I Shaw","year":"2025","unstructured":"Shaw I, Aryee AA, Ali YS, Boafo GF, Tian J, Mlambo R, et al. Harmonizing tradition and technology: liposomal nanocarriers unlocking the power of natural herbs in traditional Chinese medicine. Chin J Nat Med. 2025;23(6):700\u201313.","journal-title":"Chin J Nat Med"},{"key":"1330_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28165955","author":"C Kang","year":"2023","unstructured":"Kang C, Wang J, Li R, Gong J, Wang K, Wang Y, et al. Smart targeted delivery systems for enhancing antitumor therapy of active ingredients in traditional Chinese medicine. Molecules. 2023.","journal-title":"Molecules"},{"issue":"6","key":"1330_CR149","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754\u201363.","journal-title":"Acta Pharmacol Sin"},{"key":"1330_CR150","doi-asserted-by":"publisher","first-page":"6305295","DOI":"10.1155\/2017\/6305295","volume":"2017","author":"L Cheng","year":"2017","unstructured":"Cheng L, Zhang K, Wu S, Cui M, Xu T. Focus on mesenchymal stem cell-derived exosomes: opportunities and challenges in cell-free therapy. Stem Cells Int. 2017;2017:6305295.","journal-title":"Stem Cells Int"},{"issue":"4","key":"1330_CR151","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ejo\/cjad002","volume":"45","author":"X Zheng","year":"2023","unstructured":"Zheng X, Zhao N, Peng L, Li Z, Liu C, You Q, et al. Biological characteristics of microRNAs secreted by exosomes of periodontal ligament stem cells due to mechanical force. Eur J Orthod. 2023;45(4):408\u201317.","journal-title":"Eur J Orthod"},{"issue":"11","key":"1330_CR152","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1166\/jbn.2020.2993","volume":"16","author":"F Man","year":"2020","unstructured":"Man F, Wang J, Lu R. Techniques and applications of animal- and plant-derived exosome-based drug delivery system. J Biomed Nanotechnol. 2020;16(11):1543\u201369.","journal-title":"J Biomed Nanotechnol"},{"key":"1330_CR153","doi-asserted-by":"publisher","first-page":"115392","DOI":"10.1016\/j.ecoenv.2023.115392","volume":"264","author":"J Kong","year":"2023","unstructured":"Kong J, Kui H, Tian Y, Kong X, He T, Li Q, et al. Nephrotoxicity assessment of podophyllotoxin-induced rats by regulating PI3K\/Akt\/mTOR-Nrf2\/HO1 pathway in view of toxicological evidence chain (TEC) concept. Ecotoxicol Environ Saf. 2023;264:115392.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1330_CR154","doi-asserted-by":"publisher","first-page":"112891","DOI":"10.1016\/j.jep.2020.112891","volume":"257","author":"Q Cui","year":"2020","unstructured":"Cui Q, Zhang YL, Ma YH, Yu HY, Zhao XZ, Zhang LH, et al. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke. J Ethnopharmacol. 2020;257:112891.","journal-title":"J Ethnopharmacol"},{"issue":"47","key":"1330_CR155","doi-asserted-by":"publisher","first-page":"e31387","DOI":"10.1097\/MD.0000000000031387","volume":"101","author":"Q Wang","year":"2022","unstructured":"Wang Q, Huang P, Xia C, Fu D. Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei dihuang pill against postmenopausal osteoporosis. Medicine Baltimore. 2022;101(47):e31387.","journal-title":"Medicine Baltimore"},{"key":"1330_CR156","doi-asserted-by":"publisher","first-page":"1193846","DOI":"10.1155\/2022\/1193846","volume":"2022","author":"X Xu","year":"2022","unstructured":"Xu X, Wang L, Chen Q, Wang Z, Pan X, Peng X, et al. Decoding the mechanism of CheReCunJin formula in treating Sjogren\u2019s syndrome based on network pharmacology and molecular docking. Evid Based Complement Alternat Med. 2022;2022:1193846.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1330_CR157","doi-asserted-by":"publisher","first-page":"6657521","DOI":"10.1155\/2021\/6657521","volume":"2021","author":"Y Fang","year":"2021","unstructured":"Fang Y, Liu X, Su J. Network pharmacology analysis of traditional Chinese medicine formula Shuang di shou zhen tablets treating nonexudative age-related macular degeneration. Evid Based Complement Alternat Med. 2021;2021:6657521.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1330_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14050501","author":"MN Park","year":"2025","unstructured":"Park MN, Kim M, Lee S, Kang S, Ahn CH, Tallei TE, et al. Targeting redox signaling through exosomal microRNA: insights into tumor microenvironment and precision oncology. Antioxidants. 2025.","journal-title":"Antioxidants"},{"key":"1330_CR159","doi-asserted-by":"publisher","first-page":"107890","DOI":"10.1016\/j.phrs.2025.107890","volume":"219","author":"K Wang","year":"2025","unstructured":"Wang K, He S, Wang Y, Guo S, Zhang F, Wang Y, et al. Extracellular vesicles: a new frontier in deciphering the mechanisms of traditional Chinese medicine. Pharmacol Res. 2025;219:107890.","journal-title":"Pharmacol Res"},{"key":"1330_CR160","doi-asserted-by":"publisher","first-page":"107908","DOI":"10.1016\/j.phrs.2025.107908","volume":"219","author":"M Guo","year":"2025","unstructured":"Guo M, Guan A, Zhang M, Li H, Liu W, Wu B, et al. Exosome-mediated microglia-astrocyte interactions drive neuroinflammation in Parkinson\u2019s disease with Peli1 as a potential therapeutic target. Pharmacol Res. 2025;219:107908.","journal-title":"Pharmacol Res"},{"key":"1330_CR161","doi-asserted-by":"publisher","first-page":"157087","DOI":"10.1016\/j.phymed.2025.157087","volume":"145","author":"X Han","year":"2025","unstructured":"Han X, Zheng W, Sun Z, Luo T, Li Z, Lai W, et al. Plant-derived exosomes: unveiling the similarities and disparities between conventional extract and innovative form. Phytomedicine. 2025;145:157087.","journal-title":"Phytomedicine"},{"key":"1330_CR162","doi-asserted-by":"publisher","first-page":"123788","DOI":"10.1016\/j.ijpharm.2024.123788","volume":"651","author":"M Tsakiri","year":"2024","unstructured":"Tsakiri M, Ghanizadeh Tabriz A, Naziris N, Rahali K, Douroumis D, Demetzos C. Exosome-like genistein-loaded nanoparticles developed by thin-film hydration and 3D-printed Tesla microfluidic chip: a comparative study. Int J Pharm. 2024;651:123788.","journal-title":"Int J Pharm"},{"key":"1330_CR163","doi-asserted-by":"publisher","first-page":"12363","DOI":"10.2147\/IJN.S542641","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Shi C, Yan L, Zhang X, Ji X, Li L, et al. The application of exosomes from different sources loaded with natural small-molecule compounds in disease. Int J Nanomed. 2025;20:12363\u201392.","journal-title":"Int J Nanomed"},{"key":"1330_CR164","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jconrel.2020.12.053","volume":"330","author":"G Kim","year":"2021","unstructured":"Kim G, Lee Y, Ha J, Han S, Lee M. Engineering exosomes for pulmonary delivery of peptides and drugs to inflammatory lung cells by inhalation. J Control Release. 2021;330:684\u201395.","journal-title":"J Control Release"},{"key":"1330_CR165","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","volume":"341","author":"H Li","year":"2022","unstructured":"Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, et al. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Control Release. 2022;341:16\u201330.","journal-title":"J Control Release"},{"key":"1330_CR166","doi-asserted-by":"publisher","first-page":"123416","DOI":"10.1016\/j.carbpol.2025.123416","volume":"357","author":"L Sun","year":"2025","unstructured":"Sun L, Liu Y, Sun Q, Wang G, Du B, Liu B, et al. Polysaccharides from traditional Chinese medicine and their nano-formulated delivery systems for cancer immunotherapy. Carbohydr Polym. 2025;357:123416.","journal-title":"Carbohydr Polym"},{"issue":"5","key":"1330_CR167","doi-asserted-by":"publisher","first-page":"101131","DOI":"10.1016\/j.jpha.2024.101131","volume":"15","author":"C Pang","year":"2025","unstructured":"Pang C, Zhang J, Gu Y, Zhang Q, Zhao Y. The biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders. J Pharm Anal. 2025;15(5):101131.","journal-title":"J Pharm Anal"},{"key":"1330_CR168","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c00423","author":"F Yu","year":"2024","unstructured":"Yu F, Zhao X, Wang Q, Fang PH, Liu L, Du X, et al. Engineered mesenchymal stromal cell exosomes-loaded microneedles improve corneal healing after chemical injury. ACS Nano. 2024.","journal-title":"ACS Nano"},{"key":"1330_CR169","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jot.2023.06.003","volume":"41","author":"L Long","year":"2023","unstructured":"Long L, Zou G, Cheng Y, Li F, Wu H, Shen Y. MATN3 delivered by exosome from synovial mesenchymal stem cells relieves knee osteoarthritis: evidence from in vitro and in vivo studies. J Orthop Translat. 2023;41:20\u201332.","journal-title":"J Orthop Translat"},{"key":"1330_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023.","journal-title":"Cells"},{"issue":"1","key":"1330_CR171","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12951-021-00986-2","volume":"19","author":"YJ Li","year":"2021","unstructured":"Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, et al. Artificial exosomes for translational nanomedicine. J Nanobiotechnology. 2021;19(1):242.","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"1330_CR172","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.apsb.2022.11.019","volume":"13","author":"N Uddin","year":"2023","unstructured":"Uddin N, Binzel DW, Shu D, Fu TM, Guo P. Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome. Acta Pharm Sin B. 2023;13(4):1383\u201399.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1330_CR173","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41467-025-59489-5","volume":"16","author":"G Son","year":"2025","unstructured":"Son G, Song J, Park JC, Kim HN, Kim H. Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes. Nat Commun. 2025;16(1):4799.","journal-title":"Nat Commun"},{"issue":"2","key":"1330_CR174","doi-asserted-by":"publisher","first-page":"562","DOI":"10.7150\/ijbs.48782","volume":"17","author":"S Wang","year":"2021","unstructured":"Wang S, Dong Y, Gong A, Kong H, Gao J, Hao X, et al. Exosomal circRNAs as novel cancer biomarkers: challenges and opportunities. Int J Biol Sci. 2021;17(2):562\u201373.","journal-title":"Int J Biol Sci"},{"key":"1330_CR175","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041415","author":"T Skotland","year":"2023","unstructured":"Skotland T, Llorente A, Sandvig K. Lipids in extracellular vesicles: what can be learned about membrane structure and function? Cold Spring Harb Perspect Biol. 2023.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"1330_CR176","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12951-023-02259-6","volume":"22","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xiong M, Tian J, Song D, Duan S, Zhang L. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnol. 2024;22(1):18.","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"1330_CR177","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw WS, Chen CA, Zhou QA. Exosomes horizontal line Nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16(11):17802\u201346.","journal-title":"ACS Nano"},{"key":"1330_CR178","doi-asserted-by":"publisher","first-page":"122668","DOI":"10.1016\/j.lfs.2024.122668","volume":"347","author":"N Hasaniani","year":"2024","unstructured":"Hasaniani N, Nouri S, Shirzad M, Rostami-Mansoor S. Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology. Life Sci. 2024;347:122668.","journal-title":"Life Sci"},{"issue":"1","key":"1330_CR179","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12951-025-03321-1","volume":"23","author":"L Liu","year":"2025","unstructured":"Liu L, Zhang S, Ren Y, Wang R, Zhang Y, Weng S, et al. Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential. J Nanobiotechnol. 2025;23(1):319.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1330_CR180","doi-asserted-by":"publisher","first-page":"e0170628","DOI":"10.1371\/journal.pone.0170628","volume":"12","author":"I Helwa","year":"2017","unstructured":"Helwa I, Cai J, Drewry MD, Zimmerman A, Dinkins MB, Khaled ML, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS ONE. 2017;12(1):e0170628.","journal-title":"PLoS ONE"},{"issue":"35","key":"1330_CR181","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1039\/D2TB00494A","volume":"10","author":"L Liu","year":"2022","unstructured":"Liu L, Liu J, Zhou W, Sui Z, Liu J, Yang K, et al. An artificial antibody for exosome capture by dull template imprinting technology. J Mater Chem B. 2022;10(35):6655\u201363.","journal-title":"J Mater Chem B"},{"issue":"4","key":"1330_CR182","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10529-023-03353-3","volume":"45","author":"E Skrika-Alexopoulos","year":"2023","unstructured":"Skrika-Alexopoulos E, Mark Smales C. Isolation and characterisation of exosomes from Chinese hamster ovary (CHO) cells. Biotechnol Lett. 2023;45(4):425\u201337.","journal-title":"Biotechnol Lett"},{"issue":"24","key":"1330_CR183","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1002\/jssc.202000842","volume":"43","author":"J Li","year":"2020","unstructured":"Li J, Wang M, Wang X, Sun L, Zhao C, Zhao M. Rapid characterization of the chemical constituents of Duzhong Jiangya tablet by HPLC coupled with Fourier transform ion cyclotron resonance mass spectrometry. J Sep Sci. 2020;43(24):4434\u201360.","journal-title":"J Sep Sci"},{"issue":"21","key":"1330_CR184","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1002\/jssc.201700568","volume":"40","author":"X Li","year":"2017","unstructured":"Li X, Sun H, Zhang A, Liu Z, Zou D, Song Y, et al. High-throughput LC-MS method for the rapid characterization of multiple chemical constituents and metabolites of Da-Bu-Yin-Wan. J Sep Sci. 2017;40(21):4102\u201312.","journal-title":"J Sep Sci"},{"key":"1330_CR185","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.2147\/IJN.S526287","volume":"20","author":"Z Feng","year":"2025","unstructured":"Feng Z, Huang J, Fu J, Li L, Yu R, Li L. Medicinal plant-derived exosome-like nanovesicles as regulatory mediators in microenvironment for disease treatment. Int J Nanomed. 2025;20:8451\u201379.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1330_CR186","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13643-024-02515-2","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li J, Li X, Geng Q, Xie Y, Zhang G, et al. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis. Syst Rev. 2024;13(1):101.","journal-title":"Syst Rev"},{"key":"1330_CR187","doi-asserted-by":"publisher","first-page":"107596","DOI":"10.1016\/j.leukres.2024.107596","volume":"147","author":"S Fuji","year":"2024","unstructured":"Fuji S. Chemotherapy and allo-HSCT for young patients with aggressive ATL. Leuk Res. 2024;147:107596.","journal-title":"Leuk Res"},{"key":"1330_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030421","author":"T Richards","year":"2023","unstructured":"Richards T, Patel H, Patel K, Schanne F. Endogenous lipid carriers-bench-to-bedside roadblocks in production and drug loading of exosomes. Pharmaceuticals (Basel). 2023.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"1330_CR189","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12032-025-02742-0","volume":"42","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Hussein A, Bayani A, Dastafkan S, Amiri M, Akbari A, et al. Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders. Med Oncol. 2025;42(6):199.","journal-title":"Med Oncol"},{"issue":"1","key":"1330_CR190","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s43556-025-00280-9","volume":"6","author":"S Huang","year":"2025","unstructured":"Huang S, Yan F, Qiu Y, Liu T, Zhang W, Yang Y, et al. Exosomes in inflammation and cancer: from bench to bedside applications. Mol Biomed. 2025;6(1):41.","journal-title":"Mol Biomed"},{"key":"1330_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092276","author":"T Mori","year":"2023","unstructured":"Mori T, Giovannelli L, Bilia AR, Margheri F. Exosomes: potential next-generation nanocarriers for the therapy of inflammatory diseases. Pharmaceutics. 2023.","journal-title":"Pharmaceutics"},{"key":"1330_CR192","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","volume":"18","author":"J Tian","year":"2023","unstructured":"Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z, et al. Engineered exosome for drug delivery: recent development and clinical applications. Int J Nanomed. 2023;18:7923\u201340.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1330_CR193","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s40001-023-01556-y","volume":"28","author":"R Abbasi","year":"2023","unstructured":"Abbasi R, Mesgin RM, Nazari-Khanamiri F, Abdyazdani N, Imani Z, Talatapeh SP, et al. Mesenchymal stem cells-derived exosomes: novel carriers for nanoparticle to combat cancer. Eur J Med Res. 2023;28(1):579.","journal-title":"Eur J Med Res"},{"issue":"1","key":"1330_CR194","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-025-02372-0","volume":"24","author":"JJJ Liu","year":"2025","unstructured":"Liu JJJ, Liu D, To SKY, Wong AST. Exosomes in cancer nanomedicine: biotechnological advancements and innovations. Mol Cancer. 2025;24(1):166.","journal-title":"Mol Cancer"},{"issue":"2","key":"1330_CR195","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13402-024-00990-2","volume":"48","author":"S Araujo-Abad","year":"2025","unstructured":"Araujo-Abad S, Berna JM, Lloret-Lopez E, Lopez-Cortes A, Saceda M, de Juan Romero C. Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer. Cell Oncol (Dordr). 2025;48(2):269\u201393.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"1330_CR196","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12935-025-03731-z","volume":"25","author":"AE Basyoni","year":"2025","unstructured":"Basyoni AE, Atta A, Salem MM, Mohamed TM. Harnessing exosomes for targeted drug delivery systems to combat brain cancer. Cancer Cell Int. 2025;25(1):150.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1330_CR197","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13287-023-03288-6","volume":"14","author":"L Han","year":"2023","unstructured":"Han L, Zhao Z, He C, Li J, Li X, Lu M. Removing the stumbling block of exosome applications in clinical and translational medicine: expand production and improve accuracy. Stem Cell Res Ther. 2023;14(1):57.","journal-title":"Stem Cell Res Ther"},{"key":"1330_CR198","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.2147\/IDR.S497083","volume":"17","author":"X Ding","year":"2024","unstructured":"Ding X, Fan L, Xu L, Ma X, Meng P, Li J, et al. Incomplete immune reconstitution and Traditional Chinese Medicine in patients with HIV\/AIDS: challenges and perspectives. Infect Drug Resist. 2024;17:5827\u201338.","journal-title":"Infect Drug Resist"},{"key":"1330_CR199","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.2147\/JIR.S514060","volume":"18","author":"F Wang","year":"2025","unstructured":"Wang F, Xiong Y, Zhu Y, Yang X, Liu K, Zhu Z. Role of macrophage polarization in chronic rhinosinusitis based on the Yin-Yang theory: a review. J Inflamm Res. 2025;18:7813\u201325.","journal-title":"J Inflamm Res"},{"key":"1330_CR200","doi-asserted-by":"publisher","first-page":"1522945","DOI":"10.3389\/fphar.2025.1522945","volume":"16","author":"L Lv","year":"2025","unstructured":"Lv L, Ren S, Zhang Z, Lin H, Liu J. Clinical and basic research advances on Jinlong capsule for the prevention and treatment of liver cancer. Front Pharmacol. 2025;16:1522945.","journal-title":"Front Pharmacol"},{"key":"1330_CR201","doi-asserted-by":"publisher","first-page":"102819","DOI":"10.1016\/j.ctrv.2024.102819","volume":"130","author":"C Wang","year":"2024","unstructured":"Wang C, Fan P, Wang Q. Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer. Cancer Treat Rev. 2024;130:102819.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1330_CR202","doi-asserted-by":"publisher","first-page":"189177","DOI":"10.1016\/j.bbcan.2024.189177","volume":"1879","author":"R Farahzadi","year":"2024","unstructured":"Farahzadi R, Fathi E, Vandghanooni S, Valipour B. Hydrogel encapsulation of mesenchymal stem cells-derived extracellular vesicles as a novel therapeutic approach in cancer therapy. Biochim Biophys Acta Rev Cancer. 2024;1879(5):189177.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1330_CR203","doi-asserted-by":"publisher","first-page":"1442854","DOI":"10.3389\/fphar.2024.1442854","volume":"15","author":"T Luo","year":"2024","unstructured":"Luo T, Che Q, Guo Z, Song T, Zhao J, Xu D. Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis. Front Pharmacol. 2024;15:1442854.","journal-title":"Front Pharmacol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01330-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01330-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01330-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:02:59Z","timestamp":1769418179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01330-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01330-2","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}